From Pathophysiology to Treatment: Navigating the Challenges of Polycystic Ovary Syndrome

Polycystic Ovary Syndrome (PCOS) is a common but complex endocrine disorder that affects a significant number of women of reproductive age. It is characterized by a range of symptoms, including irregular menstrual cycles, hyperandrogenism (excessive male hormones leading to symptoms such as hirsutism and acne), and the presence of multiple cysts in the ovaries. However, PCOS is not limited to reproductive health; it has profound metabolic implications, increasing the risk of obesity, insulin resistance, Type 2 Diabetes Mellitus, and cardiovascular diseases. The pathophysiology of PCOS remains incompletely understood, but it is thought to involve hormonal imbalances, including elevated levels of luteinizing hormone (LH) and insulin resistance, which contribute to ovarian dysfunction and anovulation. The disorder’s molecular mechanisms are still being studied, with genetic and environmental factors likely playing roles in its development. One of the challenges in diagnosing PCOS is its heterogeneity, as the severity and presence of symptoms can vary greatly between individuals. This has led to multiple diagnostic criteria, with the Rotterdam Criteria being the most widely accepted, requiring at least two of the following three features: irregular ovulation, hyperandrogenism, and polycystic ovaries. Treatment for PCOS typically includes both pharmacological and non-pharmacological strategies. Pharmacologically, oral contraceptives are commonly used to regulate menstrual cycles and reduce hyperandrogenism, while medications like metformin can help address insulin resistance. Non-pharmacological approaches, such as weight management and lifestyle modifications, are also important in improving metabolic health. New avenues for research are focusing on the molecular pathways involved in PCOS, with an emphasis on developing personalized therapies that target the underlying causes of the disorder rather than just alleviating symptoms.

Publication Details

Journal
Umsida Repository (Universitas Muhammadiyah Sidoarjo)
Published
2025-03-26
Primary Topic
Astrophysics and Star Formation Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

From Pathophysiology to Treatment: Navigating the Challenges of Polycystic Ovary Syndrome

Umsida Repository (Universitas Muhammadiyah Sidoarjo)
Astrophysics and Star Formation Studies
article

From Pathophysiology to Treatment: Navigating the Challenges of Polycystic Ovary Syndrome

article en

Abstract

Polycystic Ovary Syndrome (PCOS) is a common but complex endocrine disorder that affects a significant number of women of reproductive age. It is characterized by a range of symptoms, including irregular menstrual cycles, hyperandrogenism (excessive male hormones leading to symptoms such as hirsutism and acne), and the presence of multiple cysts in the ovaries. However, PCOS is not limited to reproductive health; it has profound metabolic implications, increasing the risk of obesity, insulin resistance, Type 2 Diabetes Mellitus, and cardiovascular diseases. The pathophysiology of PCOS remains incompletely understood, but it is thought to involve hormonal imbalances, including elevated levels of luteinizing hormone (LH) and insulin resistance, which contribute to ovarian dysfunction and anovulation. The disorder’s molecular mechanisms are still being studied, with genetic and environmental factors likely playing roles in its development. One of the challenges in diagnosing PCOS is its heterogeneity, as the severity and presence of symptoms can vary greatly between individuals. This has led to multiple diagnostic criteria, with the Rotterdam Criteria being the most widely accepted, requiring at least two of the following three features: irregular ovulation, hyperandrogenism, and polycystic ovaries. Treatment for PCOS typically includes both pharmacological and non-pharmacological strategies. Pharmacologically, oral contraceptives are commonly used to regulate menstrual cycles and reduce hyperandrogenism, while medications like metformin can help address insulin resistance. Non-pharmacological approaches, such as weight management and lifestyle modifications, are also important in improving metabolic health. New avenues for research are focusing on the molecular pathways involved in PCOS, with an emphasis on developing personalized therapies that target the underlying causes of the disorder rather than just alleviating symptoms.

Umsida Repository (Universitas Muhammadiyah Sidoarjo)
Good health and well-being
Openalex Percentile: Top 55%
Astrophysics and Star Formation Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

From Pathophysiology to Treatment: Navigating the Challenges of Polycystic Ovary Syndrome · Umsida Repository (Universitas Muhammadiyah Sidoarjo) (2025) | TGRS Research Map | TGRS